Juan Pablo de Rivero Vaccari Selected Research

Inflammasomes

1/2021	Tumor necrosis factor-alpha and interferon-gamma induce inflammasome-mediated corneal endothelial cell death.
1/2021	Enoxaparin Attenuates Acute Lung Injury and Inflammasome Activation after Traumatic Brain Injury.
1/2021	Hyperoxia-activated circulating extracellular vesicles induce lung and brain injury in neonatal rats.
12/2020	Inflammasome Proteins as Inflammatory Biomarkers of Age-Related Macular Degeneration.
11/2020	ASC, IL-18 and Galectin-3 as Biomarkers of Non-Alcoholic Steatohepatitis: A Proof of Concept Study.
9/2020	Role of inflammasomes in multiple sclerosis and their potential as therapeutic targets.
6/2020	The Inflammasome Adaptor Protein ASC in Mild Cognitive Impairment and Alzheimer's Disease.
5/2020	IC100: a novel anti-ASC monoclonal antibody improves functional outcomes in an animal model of multiple sclerosis.
5/2020	Levels of caspase-1 in cerebrospinal fluid of patients with traumatic brain injury: correlation with intracranial pressure and outcome.
1/2020	Neural-respiratory inflammasome axis in traumatic brain injury.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Juan Pablo de Rivero Vaccari Research Topics

Disease

22	Inflammation (Inflammations) 05/2022 - 10/2006
15	Traumatic Brain Injuries (Traumatic Brain Injury) 05/2022 - 10/2006
10	Spinal Cord Injuries (Spinal Cord Injury) 02/2019 - 03/2008
8	Stroke (Strokes) 10/2022 - 03/2009
5	Multiple Sclerosis 09/2020 - 01/2016
5	Wounds and Injuries (Trauma) 01/2016 - 03/2008
4	Lung Injury 01/2021 - 01/2017
4	Cognitive Dysfunction 06/2020 - 12/2011
4	Brain Injuries (Brain Injury) 01/2019 - 07/2011
4	Brain Ischemia (Cerebral Ischemia) 01/2019 - 03/2009
4	Ischemia 04/2018 - 03/2009
3	Disease Progression 12/2020 - 01/2018
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 05/2020 - 01/2016
3	Infections 01/2020 - 05/2014
3	Neuroinflammatory Diseases 01/2016 - 04/2014
3	Porcine Reproductive and Respiratory Syndrome (PRRS) 08/2014 - 07/2013
2	Acute Lung Injury 01/2021 - 01/2018
2	Alzheimer Disease (Alzheimer's Disease) 06/2020 - 04/2014
2	Hyperoxia 01/2019 - 01/2017
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 02/2012
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 04/2018 - 01/2015
2	Intervertebral Disc Degeneration 11/2016 - 01/2016
2	Melanoma (Melanoma, Malignant) 04/2014 - 03/2012
2	Hypothermia 10/2012 - 10/2006
2	Contusions 03/2012 - 07/2009
1	Ischemic Stroke 10/2022
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022
1	Lupus Nephritis 01/2022
1	Macular Degeneration (Age-Related Maculopathy) 12/2020
1	Liver Diseases (Liver Disease) 11/2020
1	Alcoholic Fatty Liver 11/2020
1	Female Infertility 01/2020
1	Pre-Eclampsia (Preeclampsia) 01/2020
1	COVID-19 01/2020
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2020
1	Infertility (Sterility) 01/2020
1	Disseminated Intravascular Coagulation 01/2020
1	Endometriosis 01/2020
1	Psoriatic Arthritis 01/2020
1	Central Nervous System Diseases (CNS Diseases) 01/2020
1	Ventilator-Induced Lung Injury 01/2020
1	Infarction (Infarctions) 04/2018
1	Vascular Remodeling 01/2017
1	Bronchopulmonary Dysplasia 01/2017
1	Obesity 11/2016
1	Chronic Renal Insufficiency 11/2016
1	Encephalomyelitis (Myeloencephalitis) 05/2014

Drug/Important Bio-Agent (IBA)

42	InflammasomesIBA 01/2021 - 03/2008
20	Proteins (Proteins, Gene)FDA Link 05/2022 - 10/2006
12	CytokinesIBA 10/2022 - 03/2008
9	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2018
9	InterleukinsIBA 01/2021 - 03/2009
7	Interleukin-18 (Interleukin 18)IBA 11/2020 - 03/2009
3	CaspasesIBA 01/2022 - 10/2006
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 10/2006
3	Type I Tumor Necrosis Factor ReceptorsIBA 01/2020 - 10/2006
3	NLR ProteinsIBA 01/2016 - 07/2013
3	Pattern Recognition ReceptorsIBA 08/2014 - 07/2013
2	Interleukin-6 (Interleukin 6)IBA 10/2022 - 01/2020
2	Caspase 1 (ICE Protease)IBA 01/2022 - 01/2016
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2021 - 01/2020
2	Enoxaparin (Lovenox)FDA LinkGeneric 01/2021 - 01/2020
2	Monoclonal AntibodiesIBA 05/2020 - 01/2020
2	Estrogen Receptor betaIBA 04/2018 - 02/2016
2	salicylhydroxamic acid (SHAM)IBA 01/2018 - 07/2011
2	Interleukin-1 (Interleukin 1)IBA 01/2016 - 08/2011
2	NucleotidesIBA 01/2016 - 12/2011
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2015 - 03/2012
2	DNA (Deoxyribonucleic Acid)IBA 04/2014 - 03/2014
2	Adenosine Triphosphate (ATP)IBA 03/2014 - 07/2013
2	Interleukin-1beta (Interleukin 1 beta)IBA 07/2009 - 03/2008
2	Neutralizing AntibodiesIBA 07/2009 - 03/2009
2	X-Linked Inhibitor of Apoptosis ProteinIBA 07/2009 - 10/2006
1	Interleukin-13IBA 10/2022
1	Interleukin-2 (IL2)IBA 10/2022
1	Vascular Endothelial Growth Factor CIBA 10/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2022
1	Interleukin-4 (Interleukin 4)IBA 10/2022
1	Interleukin-8 (Interleukin 8)IBA 10/2022
1	Interleukin-16 (Interleukin 16)IBA 10/2022
1	Galectin 3 (LGALS3)IBA 11/2020
1	Dacarbazine (DIC)FDA LinkGeneric 01/2020
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2020
1	Carbon MonoxideIBA 02/2019
1	interleukin-1beta-converting enzyme inhibitorIBA 01/2019
1	N-acetyl-tyrosyl-valyl-alanyl-aspartyl chloromethyl ketoneIBA 01/2019
1	Estrogens (Estrogen)FDA Link 01/2019
1	erucylphosphocholineIBA 01/2019
1	SolutionsIBA 01/2019
1	Nicotine FDA Link 04/2018
1	Saline SolutionIBA 01/2017
1	NSC 23766IBA 01/2017
1	Insulin-Like Growth Factor I (IGF-1)IBA 11/2016
1	Multiprotein ComplexesIBA 01/2016
1	Pathogen-Associated Molecular Pattern MoleculesIBA 08/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 08/2014
1	C-Type Lectins (C-Type Lectin)IBA 08/2014

Therapy/Procedure

5	Therapeutics 01/2020 - 01/2016
2	Intraperitoneal Injections 01/2019 - 01/2017
1	Artificial Respiration (Mechanical Ventilation) 01/2020